ESMO 2026 INTELLIGENCE · MADRIDKnow what top breast cancer KOLs think about your drug — before, during and after ESMO. Six seats only.Request the brochure →
GRG Health Talk to our team
← Back to insights
Case Studies · 19 September 2026 · 1 min read

NGS Automation and the Future of Sequencing: Lab Directors Across 11 Markets, Conjoint Included

A client exploring sequencing methodologies and technologies — with a focus on automation and future trends — needed lab leadership, not lab adjacency: directors at molecular clinical diagnostic labs running NGS in-house or outsourcing it.

We fielded 90 surveys of 35 minutes across the US, UK, France, Italy, Germany, Spain, Japan, Korea, China, Singapore, and Australia, covering in-house NGS runs and automation processes, an adaptive choice-based conjoint on NGS automation, and forecasts for genomics and sequencing.

Recruitment to completion: three weeks, across eleven markets, with the conjoint build done in-house.

Hard audiences, hard method, one accountable team. Talk to our team.

Want the full read?

The complete piece, including the respondent base and methodology, is available to clients on request.

Talk to our team